Trial Profile
A multicentre, observational, open-label study of insulin-degludec and insulin-glargine in patients with type-1 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Dec 2016
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 09 Dec 2016 New trial record